Comparison of the prognostic significance of Chevallier and Sataloff's pathologic classifications after neoadjuvant chemotherapy of operable breast cancer.
about
MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 study.Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional studyWomen with large (≥3 cm) and locally advanced breast cancers (T3, 4, N1, 2, M0) receiving neoadjuvant chemotherapy (NAC: cyclophosphamide, doxorubicin, docetaxel): addition of capecitabine improves 4-year disease-free survival.Evaluation of the pathological response and prognosis following neoadjuvant chemotherapy in molecular subtypes of breast cancer.Comparison of Pathologic Response Evaluation Systems after Anthracycline with/without Taxane-Based Neoadjuvant Chemotherapy among Different Subtypes of Breast CancersERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosisA central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial.Morphological and pathological response in primary systemic therapy of patients with breast cancer and the prediction of disease free survival: a single center observational studySentinel lymph nodes for breast carcinoma: an update on current practice.Expression of Immunohistochemical Markers before and after Neoadjuvant Chemotherapy in Breast Carcinoma, and Their Use as Predictors of Response.Outcome after neoadjuvant chemotherapy in Asian breast cancer patients.Macroscopic handling and reporting of breast cancer specimens pre- and post-neoadjuvant chemotherapy treatment: review of pathological issues and suggested approaches.Modern therapies and iatrogenic changes in breast pathology.Histological assessment of therapeutic response in breast cancer.An audit of residual cancer burden reproducibility in a UK context.TERT promoter status and gene copy number gains: effect on TERT expression and association with prognosis in breast cancer.Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44).
P2860
Q27853354-34EE5C4F-7EED-4AD3-9230-B4A3B9128E00Q34567461-3D0ABE3C-9C7D-40B5-A8DB-46DEC723B19BQ35599471-BF6552F3-6690-4573-A37C-C34F822FC6F5Q35780969-595B8E20-5616-44D1-A4B0-02BC12758924Q35783711-9EE21D35-21E0-43FD-9642-A86662D1A86CQ36175526-A1A5829F-CDFD-4F6E-9626-3CBEB69595C8Q36663561-976B7296-7A0C-4EC3-9A57-41FCCF47F311Q36868191-E67ABA64-3792-4233-9E63-7A1D565C0C81Q37265272-3E14EB24-269D-46F7-81A2-4335D59AA2C8Q37484652-1A66DA75-0E87-4DB2-B660-2D2D3F5FFE07Q37609483-B8E7F85C-0646-4F02-9B6E-6CEDFE3FB89BQ38317182-DA2FE5B7-1919-461C-9146-5F648FDF90EEQ39037636-63693576-77E4-4220-B69A-A6129610E494Q39323820-11958896-54EC-452C-8CF6-E53B31F6C0BBQ39519094-06A2EF7E-22CC-40D0-BE23-33884C59538CQ44378342-7FFB435E-3985-477B-90D7-708397708239Q53752984-78CE4E9B-E667-41B7-9E4E-CB2D025CD29E
P2860
Comparison of the prognostic significance of Chevallier and Sataloff's pathologic classifications after neoadjuvant chemotherapy of operable breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparison of the prognostic s ...... apy of operable breast cancer.
@en
Comparison of the prognostic s ...... apy of operable breast cancer.
@nl
type
label
Comparison of the prognostic s ...... apy of operable breast cancer.
@en
Comparison of the prognostic s ...... apy of operable breast cancer.
@nl
prefLabel
Comparison of the prognostic s ...... apy of operable breast cancer.
@en
Comparison of the prognostic s ...... apy of operable breast cancer.
@nl
P2093
P50
P1433
P1476
Comparison of the prognostic s ...... rapy of operable breast cancer
@en
P2093
Frederique Penault-Llorca
Ines Raoelfils
Jean-Louis Achard
Marianne Leheurteur
Marie-Ange Mouret-Reynier
Philippe Chollet
Pierre Gimbergues
P304
P356
10.1016/J.HUMPATH.2007.11.019
P407
P577
2008-06-10T00:00:00Z